Vaccine trials require accurate assessment of reactogenicity and immunogenicity.
In episode five of our "Clinical Viewpoints" video series, Stephan Bart, MD, reviews approaches to modern vaccine trials and how ePRO and other technologies form a vital component of evidence generation and trial operationalization.
